Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2
- 5 May 2008
- Vol. 26 (27-28) , 3443-3451
- https://doi.org/10.1016/j.vaccine.2008.04.032
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Porcine Circovirus Type 2 Infection Decreases the Efficacy of a Modified Live Porcine Reproductive and Respiratory Syndrome Virus VaccineClinical and Vaccine Immunology, 2006
- Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in miceVaccine, 2006
- Immunogenicity of a recombinant pseudorabies virus expressing ORF1–ORF2 fusion protein of porcine circovirus type 2Veterinary Microbiology, 2005
- A Chimeric Porcine Circovirus (PCV) with the Immunogenic Capsid Gene of the Pathogenic PCV Type 2 (PCV2) Cloned into the Genomic Backbone of the Nonpathogenic PCV1 Induces Protective Immunity against PCV2 Infection in PigsJournal of Virology, 2004
- Pathogenesis of postweaning multisystemic wasting syndrome caused by Porcine circovirus 2 : an immune riddleArchiv für die gesamte Virusforschung, 2004
- Comparison of porcine circovirus type 2 load in serum quantified by a real time PCR in postweaning multisystemic wasting syndrome and porcine dermatitis and nephropathy syndrome naturally affected pigsJournal of Virological Methods, 2004
- PMWS: experimental model and co-infectionsVeterinary Microbiology, 2004
- Immunosuppression in postweaning multisystemic wasting syndrome affected pigsVeterinary Microbiology, 2004
- Immunologic Features of Porcine Circovirus Type 2 InfectionViral Immunology, 2002
- Experimental Inoculation of Conventional Pigs with Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus 2Journal of Virology, 2002